GLW declined roughly 21% over the last 30 days, falling from a $156.74 close on September 25 to $123.69 at the October 23 close. A new $2.0 billion at-the-market equity offering fueled dilution concerns and drew fresh investor scrutiny.

QLD declined roughly 11% over the past month, sliding from about $97 to near $86, as its leveraged structure amplified a pullback in the Nasdaq-100. Over the trailing three months, the fund is essentially flat (up about 1%), after surging to a record high near $100 in early October before giving back the gains.

NetClass Technology (NTCL) shares fell roughly 68% over the trailing 30 days, sliding from about $2.05 to approximately $0.66. The move was driven by a low-float, thinly-traded micro-cap reversal compounded by renewed Nasdaq minimum-bid-price compliance concerns.

Zeta Network Group (ZNB) shares fell roughly 59% over the 30 days through late October, declining from about $1.38 to $0.5661 per share. The sell-off accelerated after the company's fiscal 2026 annual report revealed a sharply wider net loss and a substantially reduced cash position.

Everspin Technologies shares fell about 31.8% over the last 30 days, declining from a closing price of $18.47 on September 25, 2026, to $12.59 on October 23, 2026. The selloff unwound a sizable portion of a strong 2026 rally, even as the company reported record quarterly results earlier in the year.

COIW has fallen roughly 24% over the past 30 days, from about $9.68 to $7.32 per share. The fund targets 1.2x (120%) of Coinbase's weekly total return, which amplifies both gains and losses.

Northern Dynasty Minerals (NAK) shares fell roughly 43.5% over the last 30 days, declining from about $1.40 to approximately $0.79. The dominant catalyst is a pending Alaska federal court ruling on the U.S. Environmental Protection Agency's (EPA) 2023 veto of the Pebble copper-gold project, a decision that remains undecided.

XBI tracks the S&P Biotechnology Select Industry Index using a modified equal-weight methodology, reducing concentration in mega-cap biopharma names. The fund holds roughly 160 biotechnology equities with a 0.35% net expense ratio and approximately $10 billion in assets under management (AUM).

FJET fell roughly 59% over the last 30 days, dropping from a closing price of $1.82 on September 25, 2026 to $0.7463 at the close on October 23, 2026. The move extends a longer decline, with shares down approximately 79% over the last quarter from around $3.55 in late July.

ONCY shares declined roughly 26.5% over the trailing 30 days, falling from about $0.68 to near $0.50. The slide reflects ongoing dilution concerns and soft small-cap biotech sentiment rather than a change in the company's clinical fundamentals, according to a Lake Street analyst note.

JetBlue Airways (JBLU) fell roughly 40% over the last 30 days, sliding from about $4.39 per share to near $2.62, as surging jet fuel costs and mounting balance-sheet concerns intensified. The stock traded near a record low in late October, with short interest climbing above 30% of the float ahead of the airline's third-quarter earnings report.

EMAG is an actively managed exchange-traded fund (ETF) that concentrates its portfolio in just three companies: Taiwan Semiconductor Manufacturing Company (TSMC), Samsung Electronics, and SK Hynix. The fund targets the largest emerging-markets semiconductor and computing companies by market capitalization, positioning itself around the physical infrastructure behind artificial intelligence (AI).

DIA tracks the 30-stock, price-weighted Dow Jones Industrial Average, offering broad blue-chip, value-oriented sector diversification at a 0.16% expense ratio. QQQ tracks the roughly 100-stock Nasdaq-100 Index of large non-financial companies, delivering diversified large-cap growth with a heavy technology tilt at 0.18%.

Qualys (QLYS) gained roughly 18.5% over the past 30 days, climbing from $182.94 to $216.70 and setting a fresh 52-week high. The move was fueled by AI-powered product launches, including TruRisk Eliminate 2.0 with TruConfidence, and a sector-wide rally tied to rising AI-enabled cyber threats.

Opposite risk profiles: SEF is an inverse (-1x) fund designed to profit when U.S. financial stocks fall, while XXX is a long-only, growth-oriented multi-asset fund blending large-cap equities with cryptocurrency exposure. Different objectives: SEF serves as a tactical hedge or short-position tool, whereas XXX aims for diversified growth through a 75% S&P 500 and 25% XRP allocation.

Different index construction: IGM tracks a broad North American technology benchmark, while QQQ tracks the Nasdaq-100 Index of the largest non-financial companies listed on Nasdaq. Holdings breadth: IGM holds roughly 290 stocks with deeper small- and mid-cap reach, whereas QQQ holds about 100–104 large-cap names.

Different mandates: VOO tracks large-cap U.S. equities through the S&P 500, while VYMI targets non-U.S. dividend payers via the FTSE All-World ex US High Dividend Yield Index. Concentration vs. breadth: VOO holds roughly 500 companies with heavy mega-cap technology weight, whereas VYMI spreads across roughly 1,500 international names dominated by financials.

Different metals, different mandates: GDX targets global gold-mining companies, while SIL targets silver-focused miners — two related but distinct precious-metals exposures. Broader versus concentrated: GDX holds roughly 55 names with its largest position near 9–11%, whereas SIL holds about 40 names with Wheaton Precious Metals near 24% of assets.

Both CBOE and CME are exchange operators that posted record financial results recently, but they derive growth from different product mixes and customer bases. CBOE is skewing toward options, index products, and data under a new CEO, while divesting smaller international businesses to sharpen focus.

Different roles in the AI boom: AMAT supplies the equipment that builds chips, while AMD designs the chips themselves, giving each a distinct risk-and-reward profile. Growth vs. value: AMD is growing revenue much faster but trades at a far higher valuation; AMAT offers a lower multiple, a dividend, and wider margins, but more cyclical demand.